YOLFTbeta
06

Theragen Etex Co.Ltd

066700 · KQ · Healthcare / Pharmaceuticals

2,050.00KRW-20.00 (-0.97%)

Price History

Full chart

Market Stats

Previous Close2,070.00
Open2,080.00
Day Range2,050.00 – 2,180.00
52-Week Range1,845.00 – 3,470.00
Volume163.25K
Market Cap82.17B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.85
50-Day Avg2,126.06
200-Day Avg2,564.97

About

Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company was formerly known as Theragen Co., Ltd. and changed its name to Theragen Etex Co.,Ltd. in July 2010. Theragen Etex Co.,Ltd. was founded in 1987 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryPharmaceuticals
  • CEOMr. Jin-Yeob Go
  • Employees165
  • HeadquartersDaegwan Building, Seoul, South Korea, 06611, Korea
  • Websitehttps://www.theragenetex.com

Leadership

  • Mr. Jin-Yeob GoChief Exec. Officer · b. 1952
  • Mr. Cho Hyung-SeokManaging Director · b. 1955

Financials

Income Statement

Currency: KRW2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue18.74B36.12B37.36B59.32B61.12B80.78B96.25B79.32B90.73B106.58B98.88B101.28B107.59B117.47B138.08B143.02B166.57B190.77B216.47B249.63B271.59B
Growth (%)-+92.77%+3.44%+58.77%+3.03%+32.16%+19.15%-17.58%+14.38%+17.47%-7.22%+2.43%+6.23%+9.19%+17.54%+3.58%+16.46%+14.53%+13.47%+15.32%+8.80%
Cost of Revenue19.91B30.32B32.15B45.11B43.61B54.52B74.05B55.82B57.47B68.42B62.73B70.18B75.09B88.83B100.37B97.44B105.39B112.90B115.80B123.64B130.58B
Gross Profit---------32.53B36.15B31.10B32.50B28.64B37.71B45.59B61.17B77.87B100.67B125.98B141.01B
Gross Margin---------30.52%36.56%30.71%30.21%24.38%27.31%31.87%36.73%40.82%46.50%50.47%51.92%
Operating Expense---------30.92B33.67B29.79B32.85B32.62B34.01B52.18B70.26B66.85B89.10B108.14B130.80B
Operating Income---1.30B2.13B3.94B--2.38B1.61B2.49B1.31B-345.47M-3.98B3.71B-6.59B-9.08B11.02B11.56B17.84B10.21B
Operating Margin---2.20%3.48%4.87%--2.63%1.51%2.51%1.29%-0.32%-3.39%2.68%-4.61%-5.45%5.78%5.34%7.15%3.76%
EBITDA-----------------20.29B41.01B-34.39B26.35B
EBITDA Margin-----------------10.64%18.94%-13.78%9.70%
Net Income----281.85M953.34M--1.33B1.60B-8.17B2.23B1.27B-10.22B43.65B-8.97B-11.85B9.56B26.21B-40.98B10.60B
Net Income Margin----0.46%1.18%--1.46%1.50%-8.26%2.20%1.18%-8.70%31.61%-6.27%-7.12%5.01%12.11%-16.42%3.90%
R&D-----1.62B4.76B4.19B3.92B3.35B3.63B3.94B3.37B4.17B-6.42B6.51B5.04B4.04B4.13B4.36B
R&D as % of Total Revenue-----2.00%4.94%5.29%4.32%3.15%3.67%3.89%3.13%3.55%-4.49%3.91%2.64%1.87%1.65%1.61%
Interest Expense00000000000000019.55M32.78M1.35B2.42B2.68B2.33B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.02%0.71%1.12%1.07%0.86%

Balance Sheet

Currency: KRW2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets45.79B42.65B52.89B73.91B88.30B98.05B100.16B113.82B120.96B125.69B137.93B140.96B145.42B174.68B241.50B534.89B350.07B246.55B243.14B237.00B257.63B
Total Liabilities35.78B31.15B34.32B47.70B42.87B48.86B44.01B42.05B41.29B43.69B69.10B68.85B58.50B93.76B105.64B160.76B127.38B102.95B90.20B106.46B98.46B
Total Equity5.36B6.69B8.45B16.02B32.84B44.12B50.89B66.36B74.02B76.15B68.82B72.10B86.93B80.92B135.86B374.12B222.70B143.60B135.70B112.15B138.99B
Cash12.78B6.49B1.12B919.28M2.32B1.55B3.89B17.78B8.29B3.39B5.47B6.37B5.17B14.79B9.81B14.25B29.93M60.31M21.73B22.21B35.35B
Total Debt----------17.20B24.61B26.93B44.07B52.28B107.22B-----
Net Debt---------------21.37B22.32B10.92B12.95B26.86B5.35B

Cash Flow

Currency: KRW2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow---3.14B-----39.95M-415.37M-8.38B1.78B-18.58B37.69M13.23B4.01B9.59B12.12B1.79B10.97B
Investing Cash Flow545.56M----6.36B----6.13B-3.66B-11.83B-8.74B-2.91B-5.64B-7.62B-2.92B1.88B-13.78B-14.02B-
Financing Cash Flow8.65B8.25B2.93B681.39M22.21B-7.39B23.78B2.23B1.03B6.23B21.14B5.83B31.03B680.48M-1.14B-3.10B-5.28B5.09B12.56B-
Capital Expenditure83.59M68.62M249.72M376.03M1.19B2.11B3.06B4.19B3.18B1.81B12.13B9.19B2.92B4.03B4.64B3.01B2.75B4.19B4.80B11.39B5.20B
Free Cash Flow---------------8.24B166.91M3.05B6.51B-12.41B5.78B
Dividends Paid850.00M------------------99.14M99.14M
FCF to OCF---------------62.29%4.17%31.79%53.68%-693.98%52.64%
Dividend Paid to FCF--------------------0.80%1.72%

Earnings

Report DateFeb 16, 2005Jul 14, 2005Mar 31, 2009Jun 30, 2009Sep 30, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 12, 2016Nov 14, 2016Mar 9, 2017May 15, 2017Aug 11, 2017Nov 14, 2017Feb 28, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Mar 7, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate159.00427.00-------------------------------------------------------------------
EPS Actual-485.20266.0032.18-86.00-37.158.98-31.81-20.5344.52-18.99-73.47-104.28-82.55-62.33-134.2713.3915.66-17.7137.8710.68-44.3324.3369.0014.754.816.90-325.2233.8620.4324.961.10-20.31-4.50-27.2592.06-36.5925.74-96.27-229.19-39.96160.612.011225.08-3.34-172.82-34.90-75.95-22.83-53.23-129.83-164.59155.3966.22149.37-72.2542.1620.02110.50652.1742.0926.02168.04-1490.70-87.0025.7791.11252.65-101.85-206.68
Surprise-405.16%-37.70%-------------------------------------------------------------------
TimingPre-marketPre-market--------------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market------------------------------

Key Statistics & Ratios

Market Cap82.17B
Enterprise Value78.46B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.29
Price / Book0.63
Revenue (TTM)188.73B
Gross Profit (TTM)61.17B
EBITDA10.44B
Profit Margin3.50%
Operating Margin2.82%
Return on Equity-3201.74%
Return on Assets1.09%
Shares Outstanding30.48M
Shares Float26.51M
Beta0.85
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20041×
100.00Dec 29, 2004